about
Adjuvant therapies for Parkinson's disease: critical evaluation of safinamideTherapy for Parkinson's disease: what is in the pipeline?Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7Antagonist effect of terguride in Parkinson's diseaseTransient cardiac arrest during continuous intravenous infusion of apomorphineCorrelation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.Novel parkin mutations detected in patients with early-onset Parkinson's disease.Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary reportThe coefficient of friction in Parkinson's disease gait.Rasagiline for the treatment of Parkinson's disease: an update.A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.A double-blind, delayed-start trial of rasagiline in Parkinson's disease.Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study.ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.Robot-assisted walking training for individuals with Parkinson's disease: a pilot randomized controlled trial.Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations.Neuroprotection in Parkinson's disease: clinical trials.Prevention and treatment of motor fluctuations.How to optimize the treatment of early stage Parkinson's disease.The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation project.Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study.Levodopa in the treatment of Parkinson's disease: current controversies.The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's diseaseThe Parkinsonian Gait Spatiotemporal Parameters Quantified by a Single Inertial Sensor before and after Automated Mechanical Peripheral Stimulation TreatmentOptimising levodopa therapy for the management of Parkinson's disease.Long-term effects of automated mechanical peripheral stimulation on gait patterns of patients with Parkinson's diseaseAbnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study.Move for change part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's diseaseAbnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations.Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications.Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.Move for Change Part II: a European survey evaluating the impact of the EPDA Charter for people with Parkinson's diseaseUrodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies.Utility of tolcapone in fluctuating Parkinson's diseaseTreatment of levodopa-induced motor complications.The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease.Classification of Healthy Subjects and Alzheimer's Disease Patients with Dementia from Cortical Sources of Resting State EEG Rhythms: A Study Using Artificial Neural Networks.
P50
Q26766289-8B927648-F207-407D-A821-F362316D1B23Q26991826-61AF55FE-3840-464B-AEC2-54B6CD2916F8Q28205082-60B7D7A6-F7BA-4133-A59F-874828587661Q28323088-59724D3D-C881-445D-83D5-7697745FC3B0Q28334413-3241C6C5-E996-41DC-B787-39DA1003B12BQ31049351-7A25B183-D592-4839-8A21-97F0010B7369Q33209648-F801154F-D02C-477A-98E5-C4D370E232AEQ33641891-D399651E-FB7D-4652-9D8F-F284E6EE48A7Q33894137-D75BD8C3-86AF-4E8F-8C79-099CE842605CQ34493883-31DD9B9B-D0A6-4FF1-8FCE-CB188EA146FFQ34611889-52C46462-CEED-4E4A-B34E-F80FF0AB90BDQ34612128-0DDA1ED8-A605-4443-8C2A-80165B4AD2C8Q34619534-8A8CBD5B-0E06-4547-BE24-740CF8CF9DA2Q34626200-B0FD4C8E-8F2D-4B05-A13F-9E50CC5F3003Q34628386-4521641C-EAD3-47F8-B020-F1A927D347A6Q34739346-20341F34-1875-49B1-89F3-134E23CE2D63Q34853030-03C68B56-3C14-43CA-AF2D-3989B333C754Q35094897-5A06B79C-AFF6-463B-ACAB-D4585C64ECB2Q35198070-EE5971B9-6561-45B8-97F7-05B2AB45546AQ35599297-3759F0CB-FB93-4CEA-9981-28ADE7402FC1Q35608939-925D0655-C8E1-4035-916E-41D6511B7250Q35808795-05CEDAC4-C894-4C71-86F5-92B08FCE8C35Q35889917-909221F9-5C9B-49E6-BCDF-3596BB9642FAQ36053229-96F668F0-3C7C-41D6-9A7D-9F04A69CDEE1Q36162824-5E80F3AC-768D-44A8-8FE0-B1E1FB5D6267Q36285098-B353001D-39F1-499B-80F9-C7A8ABF25768Q36325721-70A0A896-971B-4862-8E7D-97E301BBCEF3Q36358566-86CBC70B-0489-4793-8135-962AACE495F2Q36371466-76DC0D20-4B69-4EBC-84A4-2835693AC367Q36407197-69C0A216-DA0A-4190-A8AB-17E5FD16134AQ36521884-64C456BA-5817-4F46-8D67-68557DEBDFECQ36542313-176F5998-0B82-4E95-955D-E0E4AFF95981Q36577320-C0975B29-85DA-4B7C-BAC0-3FA5DC6B4720Q36670937-3F790AB5-A9AF-4460-B8B3-6EE1A1782101Q36905656-864D66D1-BBE4-4955-B15A-7785C931BCE3Q36993516-6F182AE2-9189-4911-8120-446754CC6730Q37018938-FEC7348F-ADD5-40A1-BF50-E7693E386C83Q37264482-ACFD1BA3-BEE7-45B7-B4DE-B7A5AD0DCA5EQ37364849-F1DA5EEB-9A1E-4672-A636-2476CFC3106EQ37607161-0212DCF4-0692-485E-ADCF-F5D04409AD02
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
F Stocchi
@nl
F Stocchi
@sl
Fabrizio Stocchi
@en
Fabrizio Stocchi
@es
type
label
F Stocchi
@nl
F Stocchi
@sl
Fabrizio Stocchi
@en
Fabrizio Stocchi
@es
altLabel
F Stocchi
@en
Stocchi F
@en
prefLabel
F Stocchi
@nl
F Stocchi
@sl
Fabrizio Stocchi
@en
Fabrizio Stocchi
@es
P106
P1153
7005546848
P21
P2798
P31
P4012
P496
0000-0002-5763-0033